Go to Client Portal

Biofilm Basics and Beyond

Access On-Demand Webinar Here


Join NAMSA for an educational and engaging webinar that explores the widely unknown topic of biofilm. We discuss the serious health threat of biofilms to global health, the relationship between antimicrobial resistance (AMR) and biofilm and the In Vitro biofilm test models that reflect real-world challenges products face.

In nature, 80% of bacteria exist within a biofilm. When microorganisms live beneath a biofilm, they are significantly less susceptible to antimicrobial agents, antibiotics and the host’s immune system.

As it relates to medical device development, standard microbiological testing focuses almost exclusively on planktonic bacteria. This focus may lead to an underestimation of the quantity of active agent required to remove a microbial biofilm effectively. This is why testing against biofilms In Vitro is critical during preclinical development. If this step is skipped, it could lead to products failing during In Vivo testing or clinical trials.

Attendees of this webinar can expect to walk away with a better understanding of the following:

  • Biofilm basics-what they are and why they are an important consideration in preclinical testing
  • How biofilms impact medical device products
  • Various biofilm test models and recommendations


*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com

NAMSA uses a third-party provider, GoToWebinar, to host NAMSA webinars. For information related to GoToWebinar’s privacy policy and utilization of information, please contact GoToWebinar directly.